World’s Top 10 Companies in Acute Bacterial Skin and Skin Structure Infection Market in 2025: Innovation and Revenue Insights (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The global acute bacterial skin and skin structure infection market is a rapidly growing pharmaceutical and healthcare services sector that focuses on developing treatments for severe bacterial skin infections. Acute bacterial skin and skin structure infections are bacterial infections that affect both the skin and its underlying tissues. The infections exist as two distinct categories, which include complicated and uncomplicated forms. The ABSSSI market comprises the revenue that results from selling therapeutic drugs that mainly include antibiotics and from providing diagnostic services and medical interventions, which include surgical drainage to treat infections that fulfill specific clinical requirements.
BDR Pharmaceuticals International launched Dalbonova Injection to treat acute bacterial skin and skin structure infections, which occur from specific Gram-positive bacteria. The drug will be distributed in a 500 mg injection format. The United States Food and Drug Administration (FDA) granted approval for ceftobiprole medocaril sodium injection to treat adult patients who have acute bacterial skin and skin structure infections (ABSSSI) and Staphylococcus aureus bloodstream infections, and children aged 3 months to less than 18 years who have community-acquired bacterial pneumonia.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the acute bacterial skin and skin structure infection market.
Acute Bacterial Skin and Skin Structure Infection Market Size & Statistics
- The Market Size for Global Acute Bacterial Skin and Skin Structure Infection was Estimated to be worth USD 12.76 billion in 2024.
- The Market is Going to Expand at a CAGR of 9.94% between 2024 and 2035.
- The Global Acute Bacterial Skin and Skin Structure Infection Market Size is anticipated to reach USD 36.2 billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the global Acute Bacterial Skin and Skin Structure Infection market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Global Acute Bacterial Skin and Skin Structure Infection Market.
Regional growth and demand
North America is expected to grow the largest during the forecast period in the global acute bacterial skin and skin structure infection market. North America is expected to grow due to the high incidence of acute bacterial skin and skin structure infections and the availability of advanced treatments. The Asia-Pacific region is anticipated to witness the fastest growth. Focus on extensive research activity by the top pharmaceutical companies in the development of anti-MRSA drugs for ABSSSI treatment and novel product launch is responsible for the generation of higher ABSSSI treatment market revenue.
Asia Pacific is expected to generate the fastest demand during the forecast period in the global acute bacterial skin and skin structure infection market. The region's market expansion is fueled by factors including a sizable population base and a growing awareness among individuals regarding skin health concerns.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the acute bacterial skin and skin structure infection market.
Top 10 Trends in the Acute Bacterial Skin and Skin Structure Infection Market
- Merck Co Inc
- Pfizer Inc
- Melinta Therapeutics Inc
- Paratek Pharmaceuticals Inc
- Novartis AG Sandoz Inc
- AbbVie Inc
- Allergan PLC
- Nabriva Therapeutics PLC
- Basilea Pharmaceutica Ltd
- Glenmark Pharmaceuticals Ltd
- Other
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the acute bacterial skin and skin structure infection market.
- Rise of Long-Acting Antibiotics
The use of long-acting agents, dalbavancin and oritavancin, has transformed the treatment of ABSSSI. These antibiotics allow for a single-dose or two-dose regimen, which provides 1–2 weeks of coverage against Gram-positive bacteria that include MRSA. The treatment process becomes easier because patients need less frequent intravenous (IV) administration, which enables their treatment to occur in emergency departments and infusion centers instead of requiring hospital admission.
- Growth in Outpatient Treatment
The healthcare system is implementing Outpatient Parenteral Antibiotic Therapy and early hospital discharge procedures to achieve cost reductions and decrease the risk of hospital-acquired infections. The medical field now provides enhanced treatment options through long-acting agents and newly developed oral medications, which enable safe and effective treatment outside of hospital settings. The hospital system aims to enhance patient satisfaction by permitting home stays while creating additional space in medical facilities.
- Increasing Prevalence of MRSA and HCAI
Methicillin-resistant Staphylococcus aureus (MRSA) and healthcare-associated infections (HCAIs) continue to rise, particularly in diabetic and elderly populations, which creates challenges for choosing appropriate initial treatment. The prevalence of MRSA in ABSSSI has prompted a shift away from traditional β-lactams toward drugs that provide guaranteed anti-MRSA coverage.
- Rise in Chronic Diseases
The rise of diabetes, obesity and immunocompromised states has resulted in more people developing severe complicated skin infections. The expanding patient base requires new treatment methods that can effectively handle both infections and their related metabolic conditions.
- Focus on New Drug Development
Pharmaceutical companies are investing heavily in research and development to create antibiotics that can combat multidrug resistance through their research on lipoglycopeptides and oxazolidinone compounds. The development process aims to achieve three objectives, which include better treatment results and fewer adverse effects and the creation of medications that can be administered through intravenous and oral methods.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the global acute bacterial skin and skin structure infection market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Are you ready to discover more about the acute bacterial skin and skin structure infection market?
The report provides an in-depth analysis of the leading companies operating in the global acute bacterial skin and skin structure infection market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the acute bacterial skin and skin structure infection market.
Company Profiles
- 1. Merck & Co., Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- Pfizer Inc.
- Melinta Therapeutics, Inc.
- Paratek Pharmaceuticals, Inc.
- Novartis AG / Sandoz Inc
- AbbVie Inc
- Allergan PLC
- Nabriva Therapeutics PLC
- Basilea Pharmaceutica Ltd
- Glenmark Pharmaceuticals Ltd.
- Other
Our Top Industry Reports:
https://www.sphericalinsights.com/reports/china-foodservice-market
https://www.sphericalinsights.com/reports/europe-lpg-market
https://www.sphericalinsights.com/reports/united-kingdom-swine-vaccines-market
Conclusion
The global acute bacterial skin and skin structure infection market is driven by the increasing prevalence of bacterial infections, rising cases of MRSA and healthcare-associated infections, and the growing burden of chronic diseases such as diabetes and obesity. Major pharmaceutical companies such as Merck & Co., Pfizer, Novartis/Sandoz, and AbbVie are actively investing in research and development to introduce innovative therapies that address antimicrobial resistance and improve treatment effectiveness. North America currently dominates the market due to advanced healthcare infrastructure, high disease prevalence, and strong pharmaceutical presence, while Asia-Pacific is expected to experience the fastest growth owing to its large population base, increasing awareness of skin health, and expanding healthcare investments.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
Need help to buy this report?